Search
Glutathione
go.drugbank.com/drugs/DB00143ApprovedInvestigationalNutraceuticalA tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.
Mixtures: Essential Pro ALPHA-G Q10 CapsulePhenprobamate
go.drugbank.com/drugs/DB13354InvestigationalMixtures: KUILIL 200 MG/200 MG FİLM TABLET, 40 TABLET, KUIFLEX 200 MG/200 MG FİLM KAPLI TABLET, 40 ADETProducts: GAMAFLEX 400 MG FİLM KAPLI TABLET, 40 ADETTocilizumab
go.drugbank.com/drugs/DB06273ApprovedInvestigational[A193281] Tocilizumab was granted FDA approval on 8 January 2010 to treat a number of inflammatory and autoimmune disorders, such as different types of arthritis and cytokine release syndrome. … [L12789] It was later approved by Health Canada on 30 April 2010.
Products: ACTEMRA® CONCENTRADO PARA INFUNSION 80 MG/4ML, ACTEMRA® CONCENTRADO PARA INFUSION 80 MG/4MLCyromazine
go.drugbank.com/drugs/DB20549ExperimentalCyromazine has a monoisotopic molecular weight of 166.1 Da.
Categories: Compounds used in a research, industrial, or household settingGlucarpidase
go.drugbank.com/drugs/DB08898ApprovedInvestigationalThis can lead to delayed renal clearance of methotrexate and elevated drug plasma levels, increasing the risk of methotrexate toxicity. … [A7476,A7477] After the discovery of certain bacteria with the capacity to inactivate folate analogs such as methotrexate, carboxypeptidase G was identified and Carboxypeptidase G1 was first isolated
Calcium lactate gluconate
go.drugbank.com/drugs/DB13365InvestigationalMixtures: CALCIUM SANDOZ FORTE 300 MG/2940 MG EFERVESAN TABLET, 20 ADET, CALCIUM SANDOZ FORTE 300 MG/2940 MG EFERVESAN TABLET, 10 ADETMethyl red
go.drugbank.com/drugs/DB08209ExperimentalSynonyms: o-Methyl red, o-((p-(Dimethylamino)phenyl)azo)benzoic acidCategories: Compounds used in a research, industrial, or household settingDeoxycholic acid
go.drugbank.com/drugs/DB03619ApprovedInvestigationalIn April 2015, deoxycholic acid was approved by the FDA for the treatment submental fat to improve aesthetic appearance and reduce facial fullness or convexity.
Products: BELKYRA INJECTION 10 MG/ML, Belkyra 10 mg/ml InjektionslösungSibeprenlimab
go.drugbank.com/drugs/DB18919ApprovedInvestigational[L54633] APRIL is a member of the tumour necrosis factor superfamily that regulates and modulates activated B cells. … [L54633] On November 25, 2025, sibeprenlimab was granted accelerated approval by the FDA to reduce proteinuria in adults with primary IgAN at risk for disease progression.[L54628]
Pemoline
go.drugbank.com/drugs/DB01230ApprovedIllicitWithdrawnIn March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.